NASDAQ: NBIX
Neurocrine Biosciences Inc Stock Ownership - Who owns Neurocrine Biosciences?

Insider buying vs selling

Have Neurocrine Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jude OnyiaChief Scientific Officer2025-07-0220,362$84.74
$1.73MBuy
Jude OnyiaChief Scientific Officer2025-07-0220,362$130.13
$2.65MSell
Kevin Charles GormanDirector2025-05-279,613$120.38
$1.16MSell
Julie CookeChief Human Resources Officer2025-05-166,468$61.82
$399.85kBuy
William H. RastetterDirector2025-05-0530,000$42.76
$1.28MBuy
William H. RastetterDirector2025-05-0530,000$110.20
$3.31MSell
Eiry RobertsChief Medical Officer2025-02-14500$115.04
$57.52kSell
Eiry RobertsChief Medical Officer2025-02-131,114$116.91
$130.23kSell
Eiry RobertsChief Medical Officer2025-02-13604$116.74
$70.51kSell
David W. BoyerChief Corp. Affairs Officer2025-02-13955$116.79
$111.54kSell

1 of 10

NBIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBIX insiders and whales buy or sell their stock.

NBIX Shareholders

What type of owners hold Neurocrine Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P35.42%35,058,600$4.68BInsider
Blackrock Inc14.84%14,682,394$1.96BInstitution
Vanguard Group Inc10.05%9,941,887$1.33BInstitution
Dodge Cox5.59%5,534,624$738.93MInstitution
State Street Corp4.91%4,862,116$649.14MInstitution
Jpmorgan Chase Co2.70%2,670,998$356.60MInstitution
Renaissance Technologies LLC2.53%2,502,697$334.14MInstitution
Wellington Management Group LLP2.12%2,097,981$280.10MInstitution
Geode Capital Management LLC1.99%1,969,754$262.98MInstitution
Bellevue Group Ag1.84%1,820,000$242.99MInstitution

1 of 3

NBIX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBIX70.23%29.77%Net SellingNet Selling
RDY13.12%0.00%
VTRS81.63%18.14%Net SellingNet Buying
RGC0.00%0.00%
TEVA62.02%0.79%Net SellingNet Selling

Neurocrine Biosciences Stock Ownership FAQ

Who owns Neurocrine Biosciences?

Neurocrine Biosciences (NASDAQ: NBIX) is owned by 95.52% institutional shareholders, 40.49% Neurocrine Biosciences insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Neurocrine Biosciences shareholder, owning 35.06M shares representing 35.42% of the company. Bvf Partners L P's Neurocrine Biosciences shares are currently valued at $4.73B.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.